Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis

Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) has been proposed as curative approach for advanced cutaneous T–cell lymphomas (CTCL). Currently, there is no established consensus for the management of disease relapse after alloHSCT. Results: Ten patients, previously treate...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Med (Lausanne)
Главные авторы: Dimitriou, Florentia, Schanz, Urs, Nair, Gayathri, Kimeswenger, Susanne, Brüggen, Marie-Charlotte, Hoetzenecker, Wolfram, French, Lars E., Dummer, Reinhard, Cozzio, Antonio, Guenova, Emmanuella
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Medicine
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344271/
https://ncbi.nlm.nih.gov/pubmed/32714935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00290
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы